SPECT/CT-guided elective nodal irradiation for head and neck cancer is oncologically safe and less toxic: A potentially practice-changing approach.
CONCLUSION: SPECT/CT-guided ENI is associated with a low risk of contralateral regional failure. Compared to B-ENI, SPECT/CT-guided ENI significantly reduces dysphagia, feeding tube placement, and late xerostomia and improves HRQOL.
PMID: 32240908 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: de Veij Mestdagh PD, Walraven I, Vogel WV, Schreuder WH, van Werkhoven E, Carbaat C, Donswijk ML, van den Brekel MWM, Al-Mamgani A Tags: Radiother Oncol Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | History of Medicine | HNSCC | Hypopharyngeal Cancer | Laryngeal Cancer | Nanotechnology | Oral Cancer | Oral Cavity Cancer | Oropharyngeal Cancer | Radiology | Skin Cancer | SPECT | Squamous Cell Carcinoma | Toxicology | Xerostomia
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024